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Abstract
Background: The global financial crisis and the economic and financial adjustment programme (EFAP) forced the
Portuguese government to adopt austerity measures, which also included the health sector. The aim of this study
was to analyse factors associated with HIV/AIDS patients’ length of stay (LOS) among Portuguese hospitals, and the
potential impact of the EFAP measures on hospitalizations among HIV/AIDS patients.
Methods: Data used in this analysis were collected from the Portuguese database of Diagnosis Related Groups
(DRG). We considered only discharges classified under MCD 24 created for patients with HIV infection. A total of
20,361 hospitalizations occurring between 2009 and 2014 in 41 public hospitals were included in the analysis. The
outcome was the number of days between hospital admission and discharge dates (LOS). Hierarchical Poisson
regression model with random effects was used to analyse the relation between LOS and patient, treatment and
setting characteristics. To more effectively analyse the impact of the EFAP implementation on HIV/AIDS
hospitalizations, yearly variables, as well as a variable measuring hospitals’ financial situation (current ratio) was
included.
Results: For the 5% level, having HIV/AIDS as the principal diagnosis, the number of secondary diagnoses,
the number of procedures, and having tuberculosis have a positive impact in HIV/AIDS LOS; while being
female, urgent admission, in-hospital mortality, pneumocystis pneumonia, hepatitis C, and hospital’s current
ratio contribute to the decrease of LOS. Additionally, LOS between 2010 and 2014 was significantly shorter
in comparison to 2009. Differences in LOS across hospitals are significant after controlling for these variables.
Conclusion: Following the EFAP, a number of cost-containment measures in the health sector were implemented.
Results from our analysis suggest that the implementation of these measures contributed to a significant decrease is
LOS among HIV/AIDS patients in Portuguese hospitals.
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Background
The economic and financial crisis that started in 2008
reached Portugal in 2009 and had economic and social
consequences that are still felt to this day. Portugal has
experienced recessions in 2009 (− 2.98% in GDP), 2011
(− 1.83%), 2012 (− 4.03%) and 2013 (− 1.13%) and this
was accompanied by a dramatic rise in the unemploy-
ment rate, which rose from 7.6% in 2008 to 16.2% in
2013 [1]. Due to the high level of public debt and the in-
creasing difficulty in financing its economy, the country
received a financial bailout by the European Commis-
sion, the International Monetary Fund and the European
Central Bank [2].
In the Memorandum of Understanding (MoU) signed
with the three institutions above, the Portuguese govern-
ment compromised by implementing a number of re-
forms aimed at reducing public spending. With regard
to the health sector, the MoU set a number of measures
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aimed at cost containment and increasing efficiency
within the Portuguese National Health Service (NHS)
[3]. These included severe cuts in the wages of health
care worker; the creation and implementation of clin-
ical guidelines; the reorganisation and rationalisation
of the hospital network through specialisation and
concentration of hospital and emergency services; and
setting up a system for comparing hospital perform-
ance (benchmarking) [4].
The consequences of the economic and financial crisis
on the health of the citizens and health care has been
studied all over Europe [5–7] and has generated intense
debate. However, the impact of these events on health
care use is still unclear, mainly due to lack of measures
to monitor the impact of the crisis and its consequences
on health and health care. From the demand side, one
could argue that income reductions could have an im-
pact in the use of health care services, as international
evidence shows that low-income people have a higher
use of in-patient care [8], and longer in-patient stays [9],
due to deterioration of their health status. From the sup-
ply side, budget cuts could have led hospitals to reduce
inefficiencies but also to decrease quality of health care
provided (e.g. by reducing length of stay or decreasing
the number of admissions).
The impact of the crisis on the health of the population
has been the focus of recent research but findings are very
controversial. Following the onset of the crisis, a rise in
suicides has been observed in Greece, Spain, the UK, and
the USA [10–13]; and a rise in mental health disorders
has been observed in Greece and Spain [14–16]. Litera-
ture also suggests that there has been an increase in cases
of infectious disease, homicides, substance abuse, and
poor self-reported health in Greece [10, 17–19]. In con-
trast, there is evidence showing that economic crisis is as-
sociated with reduced mortality related to road traffic
accidents and cardiovascular events [20].
The existing evidence suggests that since austerity
measures came into effect in 2011 there has been a de-
cline in access to health care in Portugal, particularly
among vulnerable population groups who do not benefit
from user charges exemptions [21]. Other Southern
European countries, namely Greece and Spain [22, 23],
experienced a similar situation and witnessed a serious
setback in terms of the universal health coverage, popu-
lation well-being and welfare state as a result of austerity
measures [24].
The crisis led many countries to reduce budgets ear-
marked for control and prevention of infectious diseases,
including HIV [25, 26]. People living with HIV
(PLWHIV) are vulnerable group who need constant hos-
pital care both outpatient and inpatient) and, therefore,
constitute a relevant case study to evaluate how the aus-
terity measures imposed by the MoU had an impact in
health care provision. As PLWHIV are living longer
and experiencing age-associated comorbidities, hospi-
talizations have become an important indicator of
healthcare expenditure in these patients. As in the rest
of the world, in Portugal HIV-related hospitalizations
are among the most expensive. In 2008, the average
cost of treatment was 14,277 EUR/patient/year, with
the main cost-driver being ART (EUR 9598), followed
by hospitalization costs (EUR 1323) [27]. In addition,
the weight of hospitalization costs was considerably
higher for the most severely affected patients [27].
By identifying and characterising the variations in
length of stay (LOS) among HIV/AIDS hospitalizations
across different Portuguese hospitals, the aim of this
paper was to analyse the potential impact of the eco-




Data used in this analysis were collected from the Portu-
guese national database of the diagnosis related groups
(AP-DRG v21.0) managed by the Central Administration
of the Health System (ACSS). The DRG database is an-
onymous and available for scientific research. DRGs
were first introduced in Portuguese hospitals through a
pilot study in 1984 and, since the 1990s, DRGs are used
for DRG-based hospital budget allocation from the NHS
to hospitals and for DRG-based case payment from
third-party payers [28].
Currently, there is only one DRG system in Portugal
that applies to all NHS hospitals (public) and all patients
(inpatients and ambulatory surgery), with exception of
outpatients and patients treated in psychiatric and re-
habilitation healthcare settings. Private hospitals are not
included in the system. The DRG system currently in
place defines 669 DRGs within 25 Major Diagnostic Cat-
egories (MDCs), each corresponding to one organ or
physiological system [28]. The DRG system is supervised
and maintained by the ACSS within the Ministry of
Health.
In the DRG database, each record corresponds to a
discharge episode (hospitalization) and includes infor-
mation about the patient as well as information collected
during the hospitalization, including age, sex, place of
residence, type of admission (elective or urgent), dates of
hospitalization and discharge, principal diagnosis and
secondary diagnosis, procedures during hospitalization,
and outcome at discharge (dead or alive).
Study population
We considered only discharges classified under MDC
created for patients with HIV infection (MDC 24). Thus,
the dataset provided by the ACSS included 20,580
Augusto et al. BMC Health Services Research          (2019) 19:303 Page 2 of 11
discharges registered in public acute care hospitals in
the Portuguese NHS classified under MDC 24, between
1st January 2009 and 31st December 2014. For this study
we considered only those that met the following criteria:
inpatients aged 18 or older; hospitalizations from hospi-
tals with more than 10 discharges. Following these cri-
teria, 20,361 hospitalizations occurring in 41 hospitals
were included in the analysis (Fig. 1).
Unlike previous studies [29, 30], transfers were not ex-
cluded from the analysis in order to capture the dynam-
ics of the referral system among NHS hospitals. Thus,
shorter hospitalizations in smaller hospitals followed by
longer hospitalizations in bigger hospitals were all in-
cluded in this analysis. Length of stay was considered for
each patient discharged, including patients transferred
between different hospital centres (LOS was not
summed), in order to capture all hospitalizations. Trans-
fers between hospitals represented only 2.5% (n = 507)
of the total sample.
Outcomes and covariates
The outcome variable was the number of days between
hospital admission and discharge dates (LOS). The main
explanatory variable was the year, as we aimed to exam-
ine the impact of the EFAP, which was implemented in
Portugal between May 2011 and May 2014.
We examined three types of covariates: patient, treat-
ment and setting variables.
 Patient covariates considered were: gender, age (at
the date of admission), region of residence, type of
admission (elective or urgent), readmission within
30 days of discharge, in-hospital mortality, presence
of selected co-infections (Pneumocystis pneumonia,
Hepatitis B, Hepatitis C, and Tuberculosis), HIV/
AIDS as principal diagnosis at admission, and the
number of secondary diagnosis (obtained as a sum
of diagnosis apart from the main diagnosis, in 19
possible cases [29, 31]);
 Treatment covariates included: number of
procedures (obtained as a sum of procedures in 20
possible cases [29, 31]);
 Setting covariates included whether the hospital was
merged into a Hospital Centre or not, and the
hospital’s current ratio.
Pneumocystis pneumonia became a common manifest-
ation of HIV infection in the developed world during the
1980s, and frequently resulted in death. Following the
introduction of HAART in 1996, there was a dramatic
decline in the incidence of opportunistic infections in
HIV/AIDS patients (including Pneumocystis pneumo-
nia). However, despite the major benefits associated with
HAART, Pneumocystis pneumonia remains one of the
most common AIDS-defining diagnoses and most com-
mon causes of AIDS-related death, especially in
HIV-infected patients who present late into medical care
[32]. Hepatitis B and Hepatitis C are also common
co-infections among people living with HIV. The esti-
mated prevalence of hepatitis B among people living
with HIV is 5–20%; thus, approximately 2 to 4 million
people living with HIV worldwide have chronic hepatitis
B coinfection [33, 34]. It is estimated that hepatitis C af-
fects 2–15% of people living with HIV worldwide (and
up to 90% of those are people who inject drugs [35].
Likewise, Tuberculosis and HIV/AIDS constitute the
main burden of infectious disease in resource-limited
countries [36]. Some 14 million individuals worldwide
are estimated to be dually infected with HIV and Tuber-
culosis [37] and TB remains the leading cause of death
among people living with HIV [38]. The DGR database
records the principal and all secondary diagnosis (up to
19) from each discharge using ICD-9 codes. Table 1
Fig. 1 Selection profile of study population
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shows the ICD-9 codes used to identify HIV and selected
co-infections in the DRG dataset provided.
In the beginning of the 2000s, the NHS hospital net-
work was reformed. Firstly, hospitals were transformed
in public enterprises (2005) with the aim of promoting
autonomous management and improve efficiency. Sec-
ondly, some hospitals were grouped into Hospital Cen-
tres. The rationale behind the creation of Hospital
Centres was to improve efficiency through better coord-
ination between institutions providing hospital care in
the same geographical area [39]. The process of merging
hospitals toke place over for several years, this explains
why there were important changes during the study
period (2009–2014): in 2009 there were 46 hospital insti-
tutions and in 2014 there were 41, and therefore differ-
ent codes in the dataset provided by ACSS correspond
currently to the same Hospital Centre. In order to have
the same number of institutions during the study period,
hospitals were coded according to their current status,
as to simulate the Hospital Centre of which they are cur-
rently part of, and a dummy variable was added to meas-
ure the effect of this merger.
Finally, a variable measuring the hospital’s financial
situation was added to this analysis. The current ratio is
a liquidity ratio that measures a company’s ability to pay
short-term and long-term obligations. To measure this
ability, the current ratio considers the current total as-
sets of a company (both liquid and illiquid) relative to
that company’s current total liabilities [40], as follows:
Current Ratio ¼ Current Assets Current Liabilities
The annual current ratio for each hospital institution
in the DRG dataset was taken from the annual report
and accounts from each hospital between 2009 and
2014.
Statistical analysis
The skewness and heterogeneity of LOS is a challenge
for statistical analysis [41, 42]. Particularly, HIV/AIDS
LOS has 6–7% of outliers and its distribution is very
asymmetric [31]. LOS has been analysed using many dif-
ferent methods. For example, Barbour et al. studied
changes among HIV/AIDS inpatients using a multivari-
able linear regression model [43], while Huang et al.
analysed LOS and costs based on a generalized linear
mixed model [44]. Other authors, like Wang et al., ana-
lysed maternity LOS from a two-component Poisson
mixed model [45]. However, researchers must take into
consideration that hospitalizations from the same hos-
pital are often correlated, since ignoring the dependence
of clustered data may lead to illegitimate associations
and false interpretations [42].
Hierarchical Poisson regression model was specified to
analyse the relation between LOS and the covariates. In
DRG data, patients are nested within hospitals on the
basis of their own choices which can range from place of
residence, trust in a particular doctor, or even the hospi-
tal’s reputation. This important element breaks the inde-
pendence assumptions of classical regression analysis.
Hence, hierarchical modelling is considered a more suit-
able statistical method when using multilevel structured
data, like patients clustered within hospitals [46]. Add-
itionally, the recognition of hospital random effects,
which are nevertheless important, can be used to explain
variations in hospital quality/performance [42].
Let yij (i = 1, 2,…m; j = 1, 2,…ni) the count variable
(LOS) of the j th observation (hospitalizations) in the i th
hospital, where m is the number of hospitals and
Xm
i¼1ni ¼ n
is the sample size. The generalized linear model takes
the form:
θij ¼ ηij ¼ χijβþ νi
where χij is vector with covariates with regression coeffi-
cients β, and νi is assumed to be independent and nor-
mal distribution.
We used a mediation analysis to check if year dum-
mies vary whether the current ratio is included or not.
All statistical analyses were performed using statistical
software R and its library MASS and package glmmPQL.
Results
The overall median length of stay (LOS) was 11 days
(IQR = 16). Table 2 shows the summary statistics of
hospitalization according to discharge episodes
characteristics.
Out of 20,361 discharges, 14,628 (71.8%) were male
and the median age was 44 years (IQR = 15). During the
study period, the median number of secondary diagnoses
was 7 (IQR = 5) and the median number of procedures
was 8 (IQR = 7). The majority of hospitalizations corre-
sponded to patients living in the Lisbon and the Tagus
Valley region (53.3%). During the study period (2009–
2014), there was a steady decrease in the number of hos-
pitalizations (Table 2), while the majority corresponded
to urgent admissions (83.4%). The most common
HIV-related infections among hospitalizations between
2009 and 2014 were tuberculosis (43.6%) and hepatitis C
(28.0%). In-hospital mortality during the same period
was 12.6%.
The hierarchical Poisson model as estimated by penal-
ized quasi-likelihood and the majority of covariates have
a significant impact in LOS (Table 3). Although age is
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not statistically significant, it was retained in the model
to control for possible confounding.
In contrast with the estimated coefficient of the vari-
able that measured hospital mergers, estimated coeffi-
cients of year dummies remained statistically significant
after introducing the variable current status in the
model (Table 3). Thus, adjusting for other factors, pa-
tients hospitalized during 2010 and 2011 had an esti-
mated LOS 0.092 and 0.109% lower, respectively, than
those hospitalized in 2009, while patients hospitalized
Table 2 Characteristics of HIV discharges in Portuguese NHS hospitals, 2009–2014
Variables 2009 2010 2011 2012 2013 2014 Total
Discharges, N 3864 3735 3576 3538 3146 2502 20,361
Length of stay (days); median (IQR) 11 (17) 11 (16) 11 (16) 11 (16) 11 (16) 11 (16) 11 (16)
Age (years); median (IQR) 41 (14) 43 (15) 44 (15) 44 (16) 45 (15) 46 (15) 44 (15)
No. secondary diagnoses; median (IQR) 6 (4) 6 (5) 6 (5) 7 (6) 8 (6) 8 (6) 7 (5)
No. procedures; median (IQR) 8 (6) 8 (6) 8 (6) 8 (6) 8 (7) 9 (7) 8 (7)
Gender; n (%)
Male 2783 (72.02) 2658 (71.16) 2571 (71.90) 2538 (71.74) 2282 (72.54) 1796 (71.78) 14,628 (71.84)
Female 1081 (27.98) 1077 (28.84) 1005 (28.10) 1000 (28.26) 864 (27.46) 706 (28.22) 5733 (28.16)
Region of residence; n (%)
North 1025 (16.53) 93 (25.11) 860 (24.05) 856 (24.19) 803 (25.52) 568 (22.70) 5050 (24.80)
Centre 472 (12.22) 526 (14.08) 488 (13.65) 466 (13.17) 436 (13.86) 368 (14.71) 2756 (13.54)
Lisbon and the Tagus Valley 1986 (51.40) 1968 (52.69) 1950 (54.53) 1920 (54.27) 1628 (51.75) 1396 (55.80) 10,848 (53.28)
Alentejo 50 (1.29) 45 (1.20) 39 (1.09) 40 (1.13) 34 (1.08) 29 (1.16) 237 (1.16)
Algarve 258 (6.68) 203 (5.44) 213 (5.96) 232 (6.56) 227 (7.22) 125 (5.00) 1258 (6.18)
Other 73 (1.89) 55 (1.47) 26 (0.73) 24 (0.68) 18 (0.57) 16 (0.64) 212 (1.04)
Type of admission; n (%)
Elective 533 (13.79) 14.40) 590 (16.50) 726 (20.52) 567 (18.02) 426 (17.03) 3380 (16.60)
Urgent 3331 (86.21) 3197 (85.60) 2986 (83.50) 2812 (79.48) 2579 (81.98) 2076 (82.97) 16,981 (83.40)
Readmission within 30 days; n (%)
No 3405 (88.12) 3263 (81.36) 3177 (88.84) 3141 (88.78) 2817 (89.54) 2227 (89.01) 18,030 (88.55)
Yes 459 (11.88) 472 (12.64) 399 (11.16) 397 (11.22) 329 (10.46) 275 (10.99) 2331 (11.45)
In-hospital mortality; n (%)
No 3306 (85.56) 3248 (86.96) 3140 (87.81) 3131 (88.50) 2766 (87.92) 2204 (88.09) 17,795 (87.40)
Yes 508 (14.44) 487 (13.04) 436 (12.19) 407 (11.50) 380 (12.08) 298 (11.91) 2566 (12.60)
HIV/AIDS as principal diagnosis; n (%)
No 953 (24.66) 979 (26.21) 1075 (30.06) 998 (28.21) 1108 (35.22) 512 (20.46) 5625 (27.63)
Yes 2911 (75.34) 2756 (73.79) 2501 (69.94) 2540 (71.79) 2038 (64.78) 1990 (79.54) 14,736 (72.37)
Pneumocystis pneumonia; n (%)
No 3610 (93.43) 3439 (92.07) 3315 (92.70) 3284 (92.82) 2920 (92.82) 2300 (91.93) 18,868 (92.67)
Yes 254 (6.57) 296 (7.93) 261 (7.30) 254 (7.18) 226 (7.18) 202 (8.07) 1493 (7.33)
Hepatitis B; n (%)
No 3699 (95.73) 3580 (95.85) 3382 (94.57) 3386 (95.70) 2985 (94.88) 2379 (95.08) 19,411 (95.33)
Yes 165 (4.27) 155 (4.15) 194 (5.43) 152 (4.30) 161 (5.12) 123 (4.92) 950 (4.67)
Hepatitis C; n (%)
No 2796 (72.36) 2726 (72.99) 2530 (70.75) 2520 (71.23) 2283 (72.57) 1802 (71.02) 14,657 (71.99)
Yes 1068 (27.64) 1009 (27.01) 1046 (29.25) 1018 (28.77) 863 (27.43) 700 (27.98) 5704 (28.01)
Tuberculosis; n (%)
No 2118 (54.81) 2039 (54.59) 2008 (46.15) 2100 (59.36) 1828 (58.11) 1382 (55.24) 11,475 (56.36)
Yes 1746 (45.19) 1696 (45.41) 1568 (43.85) 1438 (40.64) 1318 (41.89) 1120 (44.76) 8886 (43.64)
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in 2012, 2013 and 2014 had an estimated LOS 0.186,
0.268 and 0.262% lower than those hospitalized in
2009 (Table 3).
Adjusting for other variables, estimated LOS was lower
for hospitalizations resulting in death, for women, and for
patients with urgent admission (Table 3). Patients with ur-
gent admission had an estimated LOS 0.068% lower than
those with elective admission (Table 3). In contrast, pa-
tients with higher number of diagnosis (or higher number
of procedures) have a higher estimated HIV/AIDS LOS.
Adjusting for other variables, one additional number of
secondary diagnosis increased LOS by 0.043%, while one
additional number of procedures increased LOS by
0.085% (Table 3).
Adjusting for other factors, when analysing selected
co-morbidities, patients co-infected with Pneumocystis
pneumonia and hepatitis C had an estimated LOS 0.129
and 0.126% shorter, respectively, than those without
those co-infections (Table 3). In contrast, patients
co-infected with tuberculosis had an estimated LOS
0.391% longer than those without TB. Finally, patients
having HIV/AIDS as a principal diagnosis had an esti-
mated LOS 0.085% longer than those with other princi-
pal diagnosis (Table 3).
Hospital random effects were estimated to capture
differences in unexplained variance in LOS across
hospitals, after controlling for all other characteristics.
Figure 2 shows these random effects and their re-
spective 95% confidence intervals (IC) for the 41 hos-
pitals analysed.
For the period 2009–2014, most hospitals had an esti-
mated random effect closer to the mean value (one).
However, two hospitals (40 and 41) showed a large posi-
tive effect, extending patients’ length of stay.
Discussion
The constant decline in HIV-related hospitalizations
during the period 2009–2014 is in line with what was
observed in other studies [47]. In fact, the decrease in
HIV incidence observed in Portugal suggests success in
controlling the HIV epidemics in Portugal, following the
worldwide trend [48]. In our analysis, most HIV patients
(71.8%) hospitalized during the study period were men,
which can be explained by the fact that, like in the rest
of Europe, most of HIV patients in Portugal are men
[49]. Therefore, estimated LOS was lower for female pa-
tients and longer for male patients. Over the study
period, the median age of HIV patients hospitalized in-
creased slightly, suggesting that PLWHIV are living lon-
ger, as demonstrated by other studies [47]. While urgent
admissions have decreased steadily between 2009 and
2014 (− 37.7%) – having dropped by 10.4% between
2009 and 2011 and by 26.2% between 2012 and 2014 –
Table 3 Hierarchical Poisson regression models estimation for HIV/AIDS LOS, 2009–2014
Variables Model 1 Model 2
Coefficient p-value Coefficient p-value
Intercept 1.668 < 0.001 1.837 < 0.001
Gender (Female) −0.041 0.001 −0.039 0.011
Age −0.001 0.118 −0.001 0.137
Year 2010 (reference 2009) −0.060 0.006 −0.092 < 0.001
Year 2011 (reference 2009) −0.068 0.003 − 0.109 < 0.001
Year 2012 (reference 2009) −0.135 < 0.001 −0.186 < 0.001
Year 2013 (reference 2009) −0.214 < 0.001 −0.268 < 0.001
Year 2014 (reference 2009) −0.238 < 0.001 −0.262 < 0.001
No. secondary diagnoses 0.044 < 0.001 0.043 < 0.001
No. procedures 0.084 < 0.001 0.085 < 0.001
Urgent admission −0.069 < 0.001 − 0.068 < 0.001
Readmission within 30 days − 0.039 0.079 − 0.040 0.080
In-hospital mortality −0.139 < 0.001 −0.142 < 0.001
HIV/AIDS as principal diagnosis 0.084 < 0.001 0.085 < 0.001
Pneumocystis pneumonia −0.131 < 0.001 −0.129 < 0.001
Hepatitis C −0.126 < 0.001 −0.126 < 0.001
Tuberculosis 0.392 < 0.001 0.391 < 0.001
Hospital merge 0.081 0.001 0.046 0.066
Current ratio – – − 0.144 < 0.001
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elective admissions increased until 2012 (+ 36.2%) but
declined in the following 2 years (− 41.3%).
This study specifies a hierarchical Poisson regression
to model HIV/AIDS LOS in Portuguese public hospitals.
The estimated LOS of HIV/AIDS patients hospitalized
in each year between 2010 and 2014 was significantly
shorter than those hospitalized in 2009. A recent study
carried out in Portugal analysed all in-patient stays at all
Portuguese NHS hospitals over the 2001–2012 period
and found that the volume of in-patient stays, particu-
larly non-elective stays, increased significantly, while the
length of stay has become shorter and elective admis-
sions have decreased [1]. Although our analysis included
HIV/AIDS patients only, and the study period was dif-
ferent, we found similar results regarding the shorter
LOS and the decrease of elective admissions.
The decrease of LOS for HIV/AIDS hospitalizations
found in our analysis could be explained by two different
hypotheses. The first one is that the EFAP measures
might have induced efficiency gains, improving response
from healthcare units. In contrast, the EFAP measures
might have reduced quality of care provided in hospitals,
with a reduction of the number of in-patient beds and
increasing pressure to reduce LOS and cut costs [50].
However, our findings are not sufficient to support one
hypothesis over another and further research is needed.
Our results showed that the hospital’s financial situation
affected HIV/AIDS patients’ hospitalizations: a greater
current ratio decreased estimated LOS. This finding is
supported by other studies that show a strong negative
association between LOS and hospitals’ operating mar-
gins [51]. Long hospitalizations consume many hospital
resources and are, therefore, associated with increasing
costs. The year dummies remained statistically signifi-
cant in Model 2, even after introducing the variable
measuring hospitals’ current status. The fact that the an-
nual decrease in LOS for HIV/AIDS patients was not ex-
plained by the hospitals’ current status, suggests a
generalized pressure to reduce costs not fully related
with the hospitals’ financial situation. By 2011, NHS hos-
pitals were facing a severe financial situation, with the
total amount of arrears (accounts payable to domestic
suppliers past due date by 90 days) reaching EUR 3.0 bil-
lion [2]. Following the economic and financial adjust-
ment programme (EFAP), a number of cost-containment
measures and actions aimed at increasing efficiency in
the health sector were implemented between 2012 and
2014. The Memorandum of Understanding clearly estab-
lished the reduction of hospitals’ operating costs as a
priority, which is the reason why NHS hospitals were
under continuous pressure to cut costs during the
period of the EFAP. Our findings suggest that this was
an important contributor for the decrease of LOS among
HIV/AIDS patients.
While patients’ age is not statistically significant at the
5% level, when adjusting for other factors the estimated
LOS was significantly lower for patients who died, sug-
gesting that mortality occurs mostly at an early stage of
hospitalization. This means that there is high mortality
among those patients who are admitted at the hospital
in more severe stages of AIDS-related illness, as sup-
ported by other studies [42]. Both the number of sec-
ondary diagnoses and the number of procedures
significantly increase LOS, suggesting longer hospitaliza-
tions. A greater number of diagnoses or procedures sug-
gests a more severe condition of the patient admitted
Fig. 2 Random effects and 95% CI for each hospital
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and therefore leads to a delayed discharge [52]. Also, es-
timated LOS was longer for patients who had HIV/AIDS
as principal diagnosis, suggesting that those patients are
admitted in a more severe condition and are therefore
more likely to need a longer hospitalization.
The estimated LOS for HIV/AIDS patients was shorter
for urgent admissions. It is important to highlight that,
in Portugal, urgent admissions do not necessarily reflect
emergency situations, as noted by previous studies [42].
Due to difficulties in accessing lower levels of care, it is
not uncommon that patients seek assistance directly at a
hospital emergency service, thus bypassing primary
healthcare [53].
The variable measuring the effect of hospital mergers
into hospital centres on estimated LOS for HIV/AIDS
patients was not statistically significant in Model 2, after
introducing the variable current status. Mergers can be a
way of eliminating excess capacity and cutting costs, and
additionally they can address performance issues for par-
ticular units or services. Hospital mergers in Portugal
began in 1999 but were intensified in recent years, as a
result of the economic and financial adjustment
programme (EFAP) [4]. By concentrating within the
same administration hospitals operating in the same
geographic area and offering the same services, the aim
was to increase efficiency and promote economies of
scale. However, results from our study suggest the op-
posite, considering LOS as an indicator of hospital effi-
ciency. Regarding recent mergers, the literature suggests
that there are economies of scale and scope to explore
further, but only mergers of relatively small and similar
hospitals have been successful [54]. In fact, hospital
mergers in Portugal did not achieve the expected effi-
ciency gains due to the heterogeneity and geographical
dispersion of many hospitals. As a result, despite being
under the same administration, many hospitals kept the
same practices as they had prior to being merged with
other hospitals.
Estimated hospital random effects suggest differences
amongst hospitals which also require the need for fur-
ther research. These effects which acknowledge unex-
plained factors that are nonetheless important, can be
interpreted as differences in hospital efficiency, after
controlling for all relevant factors. Hospitals 40 and 41
showed a positive effect, extending LOS for HIV/AIDS
patients. Hospital 40 corresponds to a hospital centre in
northern Portugal, geographically disperse and with no
differentiated services, while hospital 41 is a large hos-
pital in the Lisbon metropolitan area, offering more dif-
ferentiated services.
Our study provides an analysis of relevant factors re-
lated to LOS among HIV/AIDS hospitalizations between
2009 and 2014 in Portugal. However, it is important to
note that healthcare-associated infections have a high
prevalence in Portugal – overall prevalence rate of 10.5%
in 2013 [55] – and are responsible for greater medical
costs, longer LOS, and an increase in mortality rates.
Our analysis did not include other types of pneumonia
or urinary tract infections, which are major complica-
tions from nosocomial infections, as covariates, but the
findings for pneumocystis pneumonia should prompt
further research.
Although the EFAP, in place between May 2011 and
May 2014, and the severe economic recession in Portugal
brought important social and economic consequences in
Portugal, the interpretation of our findings must be car-
ried out with caution. Between 2012 and 2014, Portugal
also witnessed changes in the National Network of Long
Term Care which was expanded and might have influ-
enced the overall reduction in LOS among patients in Por-
tuguese NHS hospitals. Our analysis did not address the
potential impact of that support network. In fact, an as-
pect of the whole system performance that is ignored in
this analysis is the impact of hospital performance on
other sectors within the health system. For instance, it
could be the case that the decrease of LOS is being se-
cured at the expense of heavy workloads for rehabilitative
and primary care services [56].
This study used comprehensive discharge data com-
piled in mainland Portugal, and these findings are more
generalizable than results based on data from a single
hospital. However, this study has limitations, due to the
nature of the data [57]. Firstly, there are limitations re-
garding the retrospective collection of data for adminis-
trative purposes, which can allow for mistakes in
recording information and/or variability of coding
among hospitals. Secondly, the DRG database has very
limited clinical information, which would have been im-
portant to better understand the clinical profile of HIV/
AIDS patients (e.g. the number of years the patient is
engaged in care, viral load, CD4 cell count, ART regime).
To track the long-term outcomes and quality of care,
further research is needed on the information system
specially implemented in NHS hospitals in Portugal to
capture these important components of HIV-related care
(SI.VIDA). Also, in this analysis, the number of second-
ary diagnosis was used as a proxy of the number of
co-morbidities, and therefore as an indicator of the pa-
tient’s condition. However, this approach reveals nothing
about the severity of each secondary diagnosis and does
not measure their severity. Future research could con-
sider the use of Elixhauser Comorbidity Index or Charl-
son Comorbidity Index [58, 59], which have been widely
utilized by health researchers to measure burden of dis-
ease and case mix.
The fact that hospital institutions were coded in the
DRG database according to the hospital centre to which
they belong may have prevented a more detailed analysis
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of the data. Although a dummy variable was considered
to capture the aggregation of hospitals into hospital cen-
tres, it would be interesting to explore, within a single
hospital centre, differences among institutions regarding
risk-adjusted LOS.
Finally, the selected study period is also a limitation
of this analysis. Although the main objective was to
measure the impact of the EFAP on hospital
in-patient care for PLWHIV, the analysis over a lon-
ger period would have allowed us to better identify
and measure the austerity effect from the long-term
trends in LOS.
Conclusions
The subject of the impacts of the economic crisis on the
health of the population has been the focus of many
studies in recent years [5–7]. Health policy research in
this field poses important methodological challenges as
it is often difficult to distinguish austerity measures from
the overall economic crisis and its impact on health sys-
tems. Therefore, the model presented in this study aims
to contribute to the analysis of the effects of the eco-
nomic and financial adjustment programme on a par-
ticular group of patients.
This study presents a hierarchical Poisson model to
analyse LOS among HIV/AIDS patients in Portuguese
public hospitals. A number of variables (HIV/AIDS as
principal diagnosis, number of secondary diagnoses,
number of procedures and tuberculosis) were found to
increase LOS, while others (in-hospital mortality, urgent
admission, Pneumocystis pneumonia and hepatitis C)
contributed to the decrease of LOS. Our findings also
show that LOS decreased during the study period, and
elective admissions decreased after 2012. Our findings
also showed that hospital’s current ratio was found to
decrease LOS, meaning that the better the financial situ-
ation, the lower the LOS for HIV/AIDS patients. With
regard to HIV/AIDS hospitalizations, two of the ana-
lysed hospitals showed a large positive effect, extending
patients’ length of stay.
These findings are a contribution to the study of the
effects of the austerity measures implemented in
Portugal between 2011 and 2014 in hospital care
provision to a particular vulnerable group of patients.
Our analysis suggests that the measures in place to cut
costs and increase efficiency in public hospitals contrib-
uted to the decrease of HIV/AIDS patients’ LOS.
Results from this analysis demonstrate the need to
further study this issue in order to better understand the
effects of the EFAP on health and health care. Addition-
ally, it would be important to implement measures to ef-
ficiently monitor health care delivery, particularly during
periods of financial constraints.
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